Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

Oral VRL offers easier administration, better quality of life, and cost saving. This study aimed to evaluate the treatment efficacy in terms of tumor response of the two formulations of vinorelbine (VRL, oral and IV) in combination with epirubicin (EPI); and the effect of EPI co-administration on VR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Chemother Pharmacol
Main Authors: Huang, Liang, Wang, Xiaojia, Zhou, Liheng, Di, Lijun, Zheng, Hongyu, Jiang, Zefei, Wang, Yongsheng, Song, Xiangqun, Feng, Jifeng, Yu, Shiying, Liu, Yunpeng, Zheng, Hong, Shen, Kunwei, Tong, Zhongsheng, Shao, Zhimin
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://ncbi.nlm.nih.gov/pubmed/31838561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-019-04000-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados